Vancomycin-resistant enterococci

Annals of the Academy of Medicine Singapore

Volumn 26, Issue 6, 1997, Pages 808-814

  Chiew, Y F ^a,b  

^a National University Hospital

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Enterococci; Review; Singapore; Vancomycin resistance

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENTEROCOCCUS; HUMAN; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NORTH AMERICA; REVIEW; SINGAPORE; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MACROLIDES; VANCOMYCIN;

EID: 0031427851     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Centers for Disease Control and Prevention Nosocomial enterococci resistant to vancomycin-United States, 1989-1993 MMWR Morb Mortal Wkly Rep 1993, 42 597-9.
2. Landman D, Mobaraki N K, Quale J M, Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin and gentamicin. Antimicrob Agents Chemother 1993; 37:1904-8.
3. Hakenbeck R. Resistance to glycopeptide antibiotics. In: Ghuysen J M, Hakenbeck R, editors. Bacterial Cell Wall. New York: Elsevier, 1994:535-45.
4. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319:157-61.
5. Uttley A H C, Collins C H, Naidoo J, George R C. Vancomycin-resistant enterococci. Lancet 1988; 1:57-8.
6. Jones R N, Sader H S, Erwin M E, Anderson S C. Prevalence data from 97 medical center surveillance study in the United States. Diagn Microbiol Infect Dis 1995; 21:85-93.
7. Paul S M, Gursky E A. A statewide surveillance for antibiotic-resistant bacteria - the New Jersey Department of Health. Infect Control Hosp Epidemiol 1996; 17-345.
8. Frieden T R, Munsiff S S, Low D E, Willey B M, Williams G, Faur Y, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342:616-7
9. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993, 42 597-9.
10. Ang S W, Seah C S, Lee S T Vancomycin-resistant Enterococcus in the Singapore National Burns Centre: a case report. Ann Acad Med Singapore 1996, 25:270-2
11. Chiew Y F, Ling M L. Two cases of vancomycin-resistant enterococci from Singapore. J Infect 1997 (In press).
12. Oon L L E, Chiew Y F. Stool carriage of vancomycin-resistant enterococci in a Singapore teaching hospital Proceedings and abstracts of the Joint Scientific Meeting of Royal College of Pathologists of Australasia, 1997 October 6-9; Singapore. Singapore: Singapore Society of Pathology and Malaysian Society of Pathologists, 1997.
13. Bonten M J, Hayden M K, Nathan C, van Voorhis J, Matushek M, Slaughter S, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci Lancet 1996, 348:1615-9.
14. Noskin G A, Stosor V, Cooper I, Peterson L R. Recovery of vancomycinresistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 1995; 16:577-81
15. Chiew Y F, Hall LMC Comparison of three methods for the molecular typing of Singapore isolates of enterococci with high-level aminoglycoside resistances. J Hosp Infect (in press).
16. Joshi N, Mulfred D, Caputo G. Vancomycin-resistant enterococci: a review. Infect Dis Clin Prac 1996; 5:528-37
17. Livornese L L, Dias S, Samel C, Romanovski B, Taylor S, May P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117:112-6.
18. Karanfil L V, Murphy M, Josephson A, Gaynes R, Mandel L, Hill B C, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13.195-200.
19. Montecalvo M A, Horowitz H, Gedris C, Carbonaro C, Tenover F C, Issah A, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit Antimicrob Agents Chemother 1994; 38 1363-7.
20. Spera R V, Farber B F Multidrug-resistant Enterococcus faecium:an untreatable nosocomial pathogen. Drugs 1994; 48:678-88.
21. Kaplan A H, Gilligan P H, Facklam R R. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 1988; 26:1216-8.
22. Emori T G, Gaynes R P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993, 6.426-42
23. Bingen E H, Denamur E, Lambert-Zechovsky N J, Elion J. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol 1991; 29:1888-92.
24. Witte W, Klare I Glycopeptide-resistant Enterococcus faecium outside hospitals: a commentary. Microbial Drug Resistance 1995; 1:259-63.
25. Klare I, Heier H, Claus H, Witte W. Environmental strains of Enterococcus faecium with inducible high level resistance to glycopeptides. FEMS Microbiol Lett 1993; 106:23-90.
26. Torres C, Reguera J A, Sanmartm M J, Perez-Diaz J C, Baquero F. vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother 1994; 33:553-61.
27. Reynolds P E Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 1989; 8:943-50.
28. Dutka-Malen S, Leclercq R, Coutant V, Duval J, Courvalin P. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria Antimicrob Agents Chemother 1990; 34.1875-9.
29. Arthur M, Molinas C, Depardieu F, Courvalin P Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcusfaecium BM4147. J Bacteriol 1993; 175:117-27.
30. Evers S, Quintiliani Jr R, Courvalin P. Genetics of glycopeptide resistance in enterococci Microbial Drug Resistance 1996; 2:219-23.
31. Meziane-Cherif D, Badet-Denisot M, Evers S, Courvalin P, Badet B. Purification and characterization of the VanB ligase associated with type B vancomycin resistance in Enterococcus faecalis V583 FEMS Microbiol Lett 1994; 354:140-2.
32. Dutka-Malen S, Molinas C, Arthur M, Courvalin P. Sequence of the vanC gene of Enterococcus gallinarum BM4147 encoding a D-alanine:D-alanine ligase related protein necessary for vancomycin resistance Gene 1992, 11253-8.
33. Swenson J M, Ferraro M J, Sahm D F, Charache P, Tenover F C. New vancomycin diffusion breakpoints for enterococci. J Clin Microbiol 1992; 30:2525-8.
34. Jordens J Z, Bates J, Griffiths D T. Faecal carnage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrobial Chemother 1994; 34:515-28.
35. Swenson J M, Clark N C, Ferraro M J, Sahm D F, Doern G, Pfaller M A, et al. Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol 1994; 32:1700-4.
36. Edberg S C, Hardalo C J, Kontruck C, Campbell S. Rapid detection of vancomycin-resistant enterococci. J Clin Microbiol 1994; 32:2182-4.
37. van-Horn K G, Gedris C A, Rodney K M. Selective isolation of vancomycin-resistant enterococci. J Clin Microbiol 1996; 34:924-7.
38. Rao G G, Ghanekar K, Ojo F. Selective medium for screening for vancomycin-resistant enterococci in faeces Eur J Clin Microbiol Infect Dis 1996, 15:175-7
39. Cartwright C P, Stock F, Fahle G A, Gill V J. Comparison of pigment production and motility tests with PCR for reliable identification of intrinsically vancomycin-resistant enterococci. J Clin Microbiol 1995, 33 1931-3.
40. van-Horn K G, Gedris C A, Rodney K M, Mitchell J B. Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci. J Clin Microbiol 1996; 34 2042-4.
41. Willey B M, Kreiswirth B N, Simor A E, Faur Y, Patel M, Williams G, et al Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1. J Clin Microbiol 1993; 31:2777-9.
42. Fontana R, Ligozzi M, Pittaluga F, Satta G. Intrinsic penicillin resistance in enterococci. Microbial Drug Resistance 1996; 2-209-13.
43. Moellering R C Jr, Wennersten C B G, Weinberg A N. Studies on antibiotic synergism against:enterococci II Effect of various antibiotics on tlie uptake of 14C-labeled streptomycin by enterococci. J Clin Invest 1971; 50 2580-4.
44. Chiew Y F Enterococcus: a much neglected bug. NUH CME Rev 1993, 3:8-12.
45. Low D E. Quinupristin/dalfopristin spectrum of activity, pharmacokinetics, and initial clinical experience. Microbial Drug Resistance 1995; 1:223-34.
46. Lynn W A, Clutterbuck E, Want S, Markides V, Lacey S, Rogers T R, et al. Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin. Lancet 1994; 344:1025-6
47. Nachamkin S A, Verma R, Egnor M Vancomycin-resistant Enterococcus faecium shunt infection in an intant. An antibiotic cure. Microbial Drug Resistance 1995, 1:95-6
48. Sahgal V S, Urban C, Mariano N, Weinbaum F, Turner J, Rahal J J, et al. Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report. Microbial Drug Resistance 1995, 1:245-7.
49. Jones R N, Johnson D M, Erwin M E. In vitro antimicrobial activities and spectra of U-1000592 and U-1000766, two novel fluorinated oxazolidinones. Antimicrob Agents Chemother 1996; 40 720-6.
50. Urban C, Mariano N, Mosinka-Snipas K, Wadee C, Chahrour T, Rahal J J. Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin. J Antimicrob Chemother 1996; 37:361-4.
51. Biavasco F, Lupidi R, Varaldo P E. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873. Antimicrob Agents Chemother 1992; 36:331-8.
52. Peetermans W E, Sebens F W, Guiot H F. Vancomycin-resistant Enterococcus faecalis in a bone-marrow transplant recipient. Scand J Infect Dis 1991; 23:105-9.
53. Lai K K. Treatment of vancomycin-resistant Enterococus faecium infections. Arch Intern Med 1996; 156.2579-84.
54. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Infect Control Hosp Epidemiol 1995; 16:105-13.